Unusual association of a pituitary adenoma and a neurological emergency: case report and diagnostic steps

Mancuso A, De Vivo A, Fanara G, Di Leo R, Toscano A (2005) Upper body venous thrombosis associated with ovarian stimulation: case report and review of the literature. Clin Exp Obstet Gynecol 32:149–154PubMedGoogle Scholar

Narayanan TJ, Chowdary GV, Murthy JM (2005) Contraceptive-related cerebral venous thrombosis with profuse vaginal bleed. Neurocrit Care 2:292–295PubMedCrossRefGoogle Scholar

Buccino G, Scoditti U, Pini M, Tagliaferri AR, Manotti C, Mancia D (1999) Low-oestrogen oral contraceptives as a major risk factor for cerebral venous and sinus thrombosis: evidence from a clinical series. Ital J Neurol Sci 20:231–235PubMedCrossRefGoogle Scholar

Strachan R, Hughes D, Cowie R (1995) Thrombosis of the straight sinus complicating hormone replacement therapy. Br J Neurosurg 9:805–808PubMedCrossRefGoogle Scholar

Brown JI, Coyne TJ, Hurlbert RJ, Fehlings MG, Ter Brugge KG (1993) Deep cerebral venous system thrombosis: case report. Neurosurgery 33:911–913PubMedCrossRefGoogle Scholar

Baldini M, Sangiovanni G (1977) Benign intracranial hypertension and thrombosis of the venous sinuses caused by contraceptive treatment. Anatomo-clinical and neuroradiological observations. G Ital Chemioter 24:117PubMedGoogle Scholar

Rousseaux P, Bernard MH, Scherpereel B, Morel M, Guyot JF (1977) Thrombosis of the intracranial venous sinuses after ingestion of estroprogestative agents. 4 cases. Nouv Presse Med 6:2049 2051–2054PubMedGoogle Scholar

Wallaschofski H, Kobsar A, Sokolova O et al (2004) Differences in platelet activation by prolactin and leptin. Horm Metab Res 36:453–457PubMedCrossRefGoogle Scholar

Wallaschofski H, Kobsar A, Koksch M et al (2003) Prolactin receptor signaling during platelet activation. Horm Metab Res 35:228–235PubMedCrossRefGoogle Scholar

Wallaschofski H, Donnè M, Eigenthaler M et al (2001) PRL as a novel potent cofactor for platelet aggregation. J Clin Endocrinol Metab 86:5912–5919PubMedCrossRefGoogle Scholar

Wallaschofski H, Eigenthaler M, Kiefer M et al (2003) Hyperprolactinemia in patients on antipsychotic drugs causes ADP-stimulated platelet activation that might explain the increased risk for venous thromboembolism: pilot study. J Clin Psychopharmacol 23:479–483PubMedCrossRefGoogle Scholar

Groote Veldman R, Frolich M, Pincus SM, Veldhuis JD, Roelfsema F (2001) Basal, pulsatile, entropic, and 24-hour rhythmic features of secondary hyperprolactinemia due to functional pituitary stalk disconnection mimic tumoral (primary) hyperprolactinemia. J Clin Endocrinol Metab 86:1562–1567CrossRefGoogle Scholar

Schroff M, deVeber G (2003) Sinovenous thrombosis in children. Neuroimaging Clin N Am 13:115–138CrossRefGoogle Scholar

Attanasio R, Orlandi P, Dallabonzana D et al (1991) Doxorubicin for acromegaly: a case report. J Endocrinol Invest 14:493–497PubMedGoogle Scholar

Nicolato A, Foroni R, Rosta L, Gerosa M, Bricolo A (2004) Multimodality stereotactic approach to the treatment of cystic craniopharyngiomas. Minim Invasive Neurosurg 47:32–40PubMedCrossRefGoogle Scholar

Zikel OM, Atkinson JL, Hurley DL (1999) Prolactinoma manifesting with symptomatic hydrocephalus. Mayo Clin Proc 74:475–477PubMedCrossRefGoogle Scholar

Scarone P, Losa M, Mortini P, Giovanelli M (2006) Obstructive hydrocephalus and intracranial hypertension caused by a giant macroprolactinoma. Prompt response to medical treatment. J Neuro Oncol 76:51–54CrossRefGoogle Scholar

Rottger C, Trittmacher S, Gerriets T, Blaes F, Kaps M, Stolz E (2005) Reversible MR imaging abnormalities following cerebral venous thrombosis. AJNR Am J Neuroradiol 26:607–613PubMedGoogle Scholar